Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Pathoanatomic Correl Between Poststroke Pathol Crying & Damage to Brain Areas Involved in Serotonergic Neurotransmission
Stroke 25:1050-1052, Andersen,G.,et al, 1994
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Restorative Neurology, Drugs and Recovery Following Stroke
Stroke 21:1636-1640, Goldstein,L.B.&Davis,J.N., 1990
Clinical, Path, & Neurochem Changes in Dementia:Subgroup with Preserved Mental Status & Neocortical Plaques
Ann Neurol 23:138-144, Katzman,R.,et al, 1988
Major Depression in Primary Dementia, Clinical and Neuropathologic Correlates
Arch Neurol 45:1182-1186, Zubenko,G.S.&Moossy,J., 1988
Alcoholic Dementia:A Hypothesis
Lancet 1:1184-1186, Lishman,W.A., 1986
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986
Neurochemical Studies of Early Onset Alzheimer's Disease, Possible Influence on Treatment
NEJM 313:7-11, Francis,P.T.,et al, 1985
Neurotransmitters & CNS Disease, Dementia
Lancet 2:1200-1204, Rossor,M.N., 1982
Reduced Dopamine-beta-hydroxylase Activity in Alzheimer's Disease
BMJ 282:93-94, Cross,A.J.,et al, 1981
Alzheimer's Disease
Editorial, BMJ 281:1374-13751980., , 1980
Neurotransmitters & the Normal & Ischemic Cerebral Circulation
NEJM 293:812, Zervas,N.T.,et al, 1975